Skip to main content

Table 1 Baseline characteristics of the study population

From: Impact of the early reduction of cyclosporine on renal function in heart transplant patients: a French randomised controlled trial

Characteristics

Low-dose group

Standard-dose group

 

(n = 47)

(n = 48)

Age, mean (SD), y

49.3 (10.2)

48.2 (11.5)

Sex

 Male n (%)

36 (76.6%)

29 (60.4%)

 Female n (%)

11 (23.4%)

19 (39.6%)

Weight, mean (SD), kg

72 (14)

69 (16)

Serum creatinine, mean (SD), μmol/L

1247 (44.2)

126.5 (47.8)

Delay to cyclosporine A (CsA) use, mean (SD), d

1.9 (1)

1.9 (1)

Pre-transplantation on heart disease:

 Idiopathic, n (%)

18 (38.3%)

18 (37.5%)

 Coronaropathy, n (%)

16 (34%)

18 (37.5%)

 Congenital cardiopathy, n (%)

2 (4.3%)

3 (63.3%)

 Valvular pathology, n (%)

1 (2.1%)

3 (63.3%)

 Other, n (%)

10 (21.3%)

6 (12.5%)

Cytomegalovirus serology

  

Donor+/Recipient-, n (%)